BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20041274)

  • 1. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
    Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
    Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L; Faurschou M; Mogensen M; Jacobsen S
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
    Sultan SM; Ioannou Y; Isenberg DA
    Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
    Wang LH; Wang WM; Lin SH; Shieh CC
    Rheumatology (Oxford); 2019 Jul; 58(7):1245-1249. PubMed ID: 30726952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.
    Joo YB; Sung YK; Shim JS; Kim JH; Lee EK; Lee HS; Bae SC
    Rheumatol Int; 2015 May; 35(5):879-86. PubMed ID: 25300729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
    Ichinose K; Sato S; Igawa T; Okamoto M; Takatani A; Endo Y; Tsuji S; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Yajima N; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Sato S; Fujiwara M; Kawakami A
    Arthritis Res Ther; 2024 Feb; 26(1):48. PubMed ID: 38347556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL).
    King JK; Costenbader KH
    Clin Rheumatol; 2007 Sep; 26(9):1491-4. PubMed ID: 17297594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
    Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
    J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
    Parikh-Patel A; White RH; Allen M; Cress R
    Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
    Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
    Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
    Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
    J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China.
    Zhou Z; Liu H; Yang Y; Zhou J; Zhao L; Chen H; Fei Y; Zhang W; Li M; Zhao Y; Zeng X; Zhang F; Yang H; Zhang X
    Cancer Commun (Lond); 2022 May; 42(5):435-446. PubMed ID: 35357093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The occurrence of malignancies in a Hungarian lupus population].
    Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center.
    Tarr T; Gyorfy B; Szekanecz E; Bhattoa HP; Zeher M; Szegedi G; Kiss E
    Ann N Y Acad Sci; 2007 Jun; 1108():76-82. PubMed ID: 17893972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of end-stage renal disease in systemic lupus erythematosus: A nationwide population-based study in Korea.
    Choi HS; Han KD; Jung JH; Kim CS; Bae EH; Ma SK; Kim SW
    Medicine (Baltimore); 2019 Jul; 98(28):e16420. PubMed ID: 31305460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study.
    Hsu CY; Lin MS; Su YJ; Cheng TT; Lin YS; Chen YC; Chiu WC; Chen TH
    Rheumatology (Oxford); 2017 Apr; 56(4):620-628. PubMed ID: 28039419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.